Pulmonary hypertension due to lung diseases and hypoxia
- I27.23 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2025 edition of ICD-10-CM I27.23 became effective on October 1, 2024.
- This is the American ICD-10-CM version of I27.23 – other international versions of ICD-10 I27.23 may differ.
Applicable To
- Group 3 pulmonary hypertension
Code Also
- associated lung disease, if known, such as:
- bronchiectasis (J47.-)
- cystic fibrosis with pulmonary manifestations (E84.0)
- interstitial lung disease (J84.-)
- pleural effusion (J90)
- sleep apnea (G47.3-)
The following code(s) above I27.23 contain annotation back-references
that may be applicable to I27.23:
ICD-10-CM I27.23 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):
- 314 Other circulatory system diagnoses with mcc
- 315 Other circulatory system diagnoses with cc
- 316 Other circulatory system diagnoses without cc/mcc
Convert I27.23 to ICD-9-CMCode History
- 2018 (effective 10/1/2017): New code
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
Diagnosis Index entries containing back-references to I27.23:
- Hypertension, hypertensive (accelerated) (benign) (essential) (idiopathic) (malignant) (systemic) I10
- pulmonaryI27.20
- due to
- lung diseases and hypoxia I27.23
- group 3 I27.23
- due to
- pulmonaryI27.20